Diabetic Ketoacidosis Global Clinical Trials Review, H1, 2016

Pages: 44 Published: May 01, 2016 Report Code: GDHC3432CTIDB

  • Overview
  • Key Players
  • Contents
  • Tables
  • Figures
  • Listen
    TTS

GlobalData's clinical trial report, “Diabetic Ketoacidosis Global Clinical Trials Review, H1, 2016" provides an overview of Diabetic Ketoacidosis clinical trials scenario. This report provides top line data relating to the clinical trials on Diabetic Ketoacidosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database – Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

– The report provides a snapshot of the global clinical trials landscape

– Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

– The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

– The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

– The Report provides enrollment trends for the past five years

– Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to Buy

Assists in formulating key business strategies with regards to investment

Helps in identifying prominent locations for conducting clinical trials which saves time and cost

Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

Supports understanding of trials count and enrollment trends by country in global therapeutics market

Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Key Players

Novo A/S

Sanofi

Pharmazz, Inc.

Alfa Wassermann S.p.A

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 3

Report Guidance 4

Clinical Trials by Region 5

Clinical Trials and Average Enrollment by Country 6

Top Countries Contributing to Clinical Trials in Asia-Pacific 8

Top Countries Contributing to Clinical Trials in Europe 9

Top Countries Contributing to Clinical Trials in North America 10

Top Countries Contributing to Clinical Trials in Middle East and Africa 11

Clinical Trials by G7 Countries: Proportion of Diabetic Ketoacidosis to Metabolic Disorders Clinical Trials 12

Clinical Trials in G7 Countries by Trial Status 14

Clinical Trials by E7 Countries: Proportion of Diabetic Ketoacidosis to Metabolic Disorders Clinical Trials 15

Clinical Trials by Phase in E7 Countries 17

Clinical Trials in E7 Countries by Trial Status 18

Clinical Trials by Phase 19

In Progress Trials by Phase 20

Clinical Trials by Trial Status 21

Clinical Trials by End Point Status 22

Subjects Recruited Over a Period of Time 23

Clinical Trials by Sponsor Type 24

Prominent Sponsors 25

Top Companies Participating in Diabetic Ketoacidosis Therapeutics Clinical Trials 26

Prominent Drugs 27

Clinical Trial Profile Snapshots 28

Appendix 41

Abbreviations 41

Definitions 41

Research Methodology 42

Secondary Research 42

About GlobalData 43

Contact Us 43

Disclaimer 43

Source 44

List of Tables

Diabetic Ketoacidosis Therapeutics, Global, Clinical Trials by Region, 2016* 5

Diabetic Ketoacidosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 6

Diabetic Ketoacidosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 7

Diabetic Ketoacidosis Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2016* 8

Diabetic Ketoacidosis Therapeutics Clinical Trials, Europe, Top Countries, 2016* 9

Diabetic Ketoacidosis Therapeutics Clinical Trials, North America, Top Countries, 2016* 10

Diabetic Ketoacidosis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2016* 11

Proportion of Diabetic Ketoacidosis to Metabolic Disorders Clinical Trials, G7 Countries (%), 2016* 12

Diabetic Ketoacidosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 14

Proportion of Diabetic Ketoacidosis to Metabolic Disorders Clinical Trials, E7 Countries (%), 2016* 15

Diabetic Ketoacidosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 17

Diabetic Ketoacidosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 18

Diabetic Ketoacidosis Therapeutics, Global, Clinical Trials by Phase, 2016* 19

Diabetic Ketoacidosis Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 20

Diabetic Ketoacidosis Therapeutics, Global, Clinical Trials by Trial Status, 2016* 21

Diabetic Ketoacidosis Therapeutics Clinical Trials, Global, by End Point Status, 2016* 22

Diabetic Ketoacidosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 23

Diabetic Ketoacidosis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 24

Diabetic Ketoacidosis Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 25

Diabetic Ketoacidosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 26

Diabetic Ketoacidosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 27

List of Figures

Diabetic Ketoacidosis Therapeutics, Global, Clinical Trials by Region (%), 2016* 5

Diabetic Ketoacidosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 6

Diabetic Ketoacidosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 7

Diabetic Ketoacidosis Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2016* 8

Diabetic Ketoacidosis Therapeutics Clinical Trials, Europe, Top Countries (%), 2016* 9

Proportion of Diabetic Ketoacidosis to Metabolic Disorders Clinical Trials, G7 Countries (%), 2016* 12

Diabetic Ketoacidosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 14

Proportion of Diabetic Ketoacidosis to Metabolic Disorders Clinical Trials, E7 Countries (%), 2016* 15

Diabetic Ketoacidosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 17

Diabetic Ketoacidosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 18

Diabetic Ketoacidosis Therapeutics, Global, Clinical Trials by Phase (%), 2016* 19

Diabetic Ketoacidosis Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 20

Diabetic Ketoacidosis Therapeutics, Global, Clinical Trials by Trial Status, 2016* 21

Diabetic Ketoacidosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 23

Diabetic Ketoacidosis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 24

Diabetic Ketoacidosis Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 25

Diabetic Ketoacidosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 26

Diabetic Ketoacidosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 27

GlobalData Methodology 42

$2500

Can be used by individual purchaser only

$7500

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 (0) 20 7947 2960

GDPR + CCPA Compliant

Personal and transaction information are kept safe from unauthorised use.

Recently Viewed Reports

Looking to stay on top of industry & market trends?

Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.